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Sets of genes under a common regulatory control in a given cell type are often differentially transcribed. The
possibility that this differential transcription can be modulated by the number or strength of cis-acting
regulatory sequences associated with a given gene was tested by using the glucocorticoid-responsive enhancer
element associated with the mouse mammary tumor virus promoter. Results indicate that differential levels of
hormone-inducible gene expression can be modulated in an additive way by the number of glucocorticoid-
responsive enhancers associated with this promoter. Realization of these effects shows little preference for
position of the additional elements with respect to the promoter. When sequences that bind the glucocorticoid
receptor in vitro with somewhat lower affinity than the enhancer were tested, these additive effects were not
detected. The results support the view that differential transcription of genes subject to a common regulatory
control can be mediated, at least in part, by the number or strength of their associated cis-acting regulatory
sequences.
The control of gene expression can, in principle, occur at
a number of levels, the most basic of which is transcription
initiation. For eucaryotic genes transcribed by RNA poly-
merase II, the DNA sequences required in cis for this kind of
control have been extensively studied in several systems (for
a review, see reference 12). One class of these sequences,
the enhancer elements (for a review, see reference 22), has
been shown to play a role in the determination of cell
specificity of viral gene transcription (5, 17) as well as in the
tissue-specific expression of endogenous cellular genes (10,
63). These elements appear to act as binding sites for
trans-acting factors (35, 47, 51) that are required for the
enhancer-directed stimulation of transcription from a linked
promoter (57, 65). An emerging view of enhancer action is
that different enhancers may act independently of one an-
other to confer different controls on a gene by two or more
distinct biochemical pathways (66). An extension of this
view is that differential regulation of transcription for a set of
genes under a common control could be conferred by the
strength or number of enhancer elements associated with
each gene (13, 33, 52).
The regulated transcription of mouse mammary tumor
virus (MMTV) provides a relevant biological system in
which to test the proposal that differential levels of transcrip-
tion can be mediated by multiple functionally related en-
hancer elements of different strength or number. The gluco-
corticoid-regulated transcription of the proviral genes of
MMTV (Fig. 1A), a retrovirus, is mediated by cis-acting
sequences that have been termed the glucocorticoid re-
sponse element (GRE). These sequences are specifically
bound by a partially purified hormone-receptor complex in
vitro (9, 16, 40-42, 48, 49) and serve to increase the rate of
transcription initiation from the MMTV promoter (60) in a
manner reminiscent of enhancer elements (6, 43). Functional
GRE sequences have been identified within the proviral long
terminal repeats (LTRs) (6, 19, 25, 30, 43) and thus are
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present twice, once at each end, in the integrated provirus.
Other sequences that bind the hormone receptor complex in
vitro have been identified within the proviral genome (40,
41), but the function of these sequences as GREs with a
defined promoter has not yet been investigated.
In this study, we used a transient-expression assay to
show that the presence of multiple GRE sequences can
differentially activate the MMTV promoter in an additive
fashion and that this increased activity is relatively indepen-
dent of the position of the GREs with respect to the
promoter. We show that such additive effects are not ob-
tained when sequences internal to the MMTV genome to
which hormone receptor complex binds with lower affinity in
vitro are placed in their normal position and orientation with
respect to the LTR.
MATERIALS AND METHODS
Plasmid constructions. pMT1 is a derivative of pSVOd
(34), a plasmid that is missing the pBR322 "poison" (29)
sequences. The simian virus 40 (SV40) origin and early
promoter signals of pSVOd were removed by linearizing
with EcoRI, filling in the ends with the Klenow fragment of
Escherichia coli DNA polymerase I (Bethesda Research
Laboratories), ligating 10-base-pair (bp) HindIII linkers
(Boehringer Mannheim Biochemicals) to these blunt ends,
digesting with HindlIl, and then recircularizing the plasmid
with T4 DNA ligase (Bethesda Research Laboratories Inc.).
A 455-bp bacteriophage M13 origin of replication was added
to this construction by replacing the AhaIII fragment of
pBR322 (positions 3232 to 3943) with the corresponding
fragment of pZ152 (67) and screening the ampicillin-resistant
colonies for the M13 origin fragment. To construct pLC1,
the 1.6-kilobase (kb) HindIII-BamHI fragment of pSV2cat
(15), which contains the chloramphenicol acetyltransferase
(CAT) coding sequences followed by the SV40 small t intron
and early poly(A) signal, was inserted between the HindlIl
and BamHI sites (pBR322 positions 29 to 375) of pMT1.
Next, a 1.5-kb HindIII fragment, modified from a 1.5-kb PstI
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FIG. 1. Structure of the MMTV provirus and MMTV-CAT plasmids. (A) Structure ofMMTV proviral DNA. The glucocorticoid response
elements (cross-hatched boxes) are contained within the LTRs (striped boxes) at each end of the proviral genome. Sites of in vitro binding
for purified glucocorticoid receptor (numbered 1 to 4) are indicated by filled boxes. The 344-bp Sau3A fragment used in these studies is
enlarged above the provirus. The 1.3-kb BamHI restriction fragment containing internal glucocorticoid binding sites 2 and 3 (40) is also shown.
Transcription of viral RNA begins in the left LTR (arrow). (B) Structure of plasmid pLC1. The 1.5-kb PstI fragment containing the MMTV
LTR (striped box) is inserted upstream of the coding sequences for the CAT gene (filled box) and the SV40 small t intron and early poly(A)
signals (open box). The vector sequences are derived from pSVOd (34), a "poison-less" (29) derivative of pBR322, into which we have
inserted a bacteriophage M13 origin of replication (stippled box) (67) after deletion of the SV40 origin-early promoter region. Inclusion of the
M13-derived sequences does not affect hormone regulation (data not shown) and is not relevant to the present study. The expected major
transcript from this plasmid is indicated (arrow). (C) Structure of plasmid pLCL1. The 191 bp of pBR322-derived sequences between the
BamHI and SphI sites (not shown) of pLC1 were replaced with an additional copy of the MMTV LTR in the orientation depicted. The scale
of pLCL1 (8.0 kb) is the same as that of pLC1 (6.5 kb) in panel B.
fragment that contains the C3H MMTV LTR (31), was
inserted upstream of the CAT gene. This HindIII fragment
was constructed such that a BamHI site was inserted 12 bp
upstream of the MMTV LTR. In this construction, the CAT
initiation codon is 308 bp downstream from the transcription
initiation site within the MMTV LTR (58), and there are no
other initiation codons 5' of the CAT open reading frame.
Plasmid pLC2 was constructed by replacing the 135-bp
PvuII-PstI fragment (positions + 134 to +269) of MMTV
DNA from pLC1 with a small region of pUC18 polylinker,
thus generating an MMTV-CAT RNA that is 139 bp shorter
than that directed by pLC1. Plasmid pLCL1 contains a
second copy of the MMTV LTR PstI fragment, after modi-
fication of the ends, between the BamHI and SphI sites of
pBR322-derived sequences in pLCl.
Plasmids containing multiple GREs were constructed by
inserting the 344-bp Sau3A fragment of the C3H MMTV
LTR (positions -112 to -455 with respect to the transcrip-
tion initiation point) into pLC1 that had been partially
digested with BamHI to create linear molecules which were
then isolated from an agarose gel with DEAE-membrane
(Schleicher & Schuell, Inc.) and treated with calf intestinal
phosphatase (Boehringer Mannheim). Plasmid p23LC1,
which contains internal binding sites 2 and 3, was created by
inserting the 1.3-kb BamHI fragment ofpMTV1 (59) into the
BamHI site downstream of the CAT gene in pLCl. The
constructions used for RNase Ti mapping probes are de-
scribed below. All plasmids were transformed into E. coli
HB101 and screened for insertion site and orientation by
restriction enzyme analysis. Supercoiled monomer plasmid
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DNA was purified by alkaline extraction (2) followed by
CsCl-ethidium bromide equilibrium density centrifugation.
Plasmid concentrations were determined by A260 and verified
by visualization after agarose gel electrophoresis-ethidium
bromide staining. Restriction enzymes (Bethesda Research
Laboratories or New England BioLabs, Inc.) were used
according to the recommendations of the supplier.
Transfections and CAT assays. Mouse Ltk- cells (23) were
grown at 37°C in Dulbecco modified Eagle medium (GIBCO
Laboratories) supplemented with 10% fetal bovine serum
(KC Biologicals) in a 5% C02, water-saturated atmosphere.
Transfections were by the DEAE-dextran-dimethylsulfoxide
(DMSO) shock procedure (28). The day before transfection,
approximately 1.5 x 105 cells were seeded onto 100-mm
tissue culture dishes (Corning Glass Works). The next day,
the medium was replaced with 3.0 ml of Dulbecco modified
Eagle medium containing 200 ,ug of DEAE-dextran
(Pharmacia, Inc.) per ml, penicillin and streptomycin (100
U/ml and 100 ,ug/ml, respectively; GIBCO), and DNA (1.2
nM). After 4 h (37°C, 5% CO2) this mixture was replaced
with 2.5 ml of 137 mM NaCl-5 mM KCl-0.7 mM Na2HPO4-6
mM dextrose-21 mM HEPES [N-2-hydroxyethylpiperazine-
N'-2-ethanesulfonic acid] [pH 7.11 containing 10% DMSO
(Sigma Chemical Co.). After a 2-min incubation at room
temperature, the cells were washed once with phosphate-
buffered saline (2.7 mM KCl, 1.5 mM KH2PO4, 137 mM
NaCl, 15 mM Na2HPO4), and 10.0 ml of Dulbecco modified
Eagle medium containing 10% fetal bovine serum, penicillin,
and streptomycin was added. For cells receiving hormone
treatment, the synthetic glucocorticoid dexamethasone
(Sigma) was added to a final concentration of 10-7 M 40 h
after the DMSO shock. At 58 h after the DMSO shock, the
cells were harvested, crude extracts were made by three
freeze-thaw cycles, and the protein concentrations of the
extracts were determined (3) with bovine serum albumin as
the standard. CAT enzyme activities were determined in a
reaction containing 460 mM Tris hydrochloride (pH 7.8),
0.53 mM acetyl coenzyme A (Pharmacia), 23 FM
[14C]chloramphenicol (50 mCi/mmol; New England Nu-
clear), and 15 to 40 ,ug of cellular protein, depending upon
the experiment. Reactions proceeded for 30 min at 37°C and
were stopped by extraction of chloramphenicol and its
acetylated derivatives with 1.0 ml of ethyl acetate (J. T.
Baker Chemical Co.). The acetylated products were sepa-
rated from the chloramphenicol substrate by ascending
thin-layer chromatography in chloroform-methanol (95:5)
and were viewed by overnight exposure to XAR-5 film
(Eastman Kodak Co.). For quantitation, the spots were cut
from the chromatography plates, and radioactivity was de-
termined by liquid scintillation counting. Under these con-
ditions, extracts of cells transfected with pLC1 resulted in a
CAT specific activity of 0.65 nmol acetylated per min per mg
of protein.
Probe constructions and quantitative RNase Tl mapping.
The MMTV LTR probe was derived from a 1.5-kb PstI
restriction fragment which contains most of the MMTV LTR
(31) cloned into the PstI site of pUC8 (61). This LTR
fragment wvas then removed from the pUC8 vector by
digestion with HindIlI and EcoRI and cloned into the
HindIll and EcoRI sites of the SP6/T7 expression vector
pGEM1 (50) to generate pGLTR1.2. For the dexamethasone
induction time course experiment, pGLTR1.2 was linearized
with ClaI, and a 1,170-nucleotide RNA probe (complemen-
tary to positions -861 to +274 of the MMTV LTR) was
synthesized in vitro with T7 RNA polymerase. For RNase
Tl mapping experiments, pGLTR1.2 was linearized with
SstI, the ends were made blunt with Klenow DNA polymer-
ase (5 U/,g for 20 min at 25°C in 10 mM Tris hydrochloride
[pH 8.0]-100 mM NaCl-10 mM MgGl2) (New England
BioLabs), and the 414-nucleotide probe (complementary to
positions -105 to +274 of the MMTV LTR) was synthesized
with T7 RNA polymerase. The mouse ,-tubulin cDNA
(kindly provided by D. Cleveland), consisting of sequences
corresponding to codons 1 to 406 (27), was cloned into the
EcoRI site of pGEM1 and screened for orientation by
restriction enzyme mapping. This clone was digested with
BamHI, and a 212-nucleotide probe (complementary to 194
nucleotides of P-tubulin RNA) was synthesized with T7
RNA polymerase.
The RNA probe synthesis reactions were performed in a
volume of 20 ,ul containing 20 ng of template DNA, 15 U of
T7 RNA polymerase (Bethesda Research Laboratories), 40
U of RNasin (Promega Biotech), transcription buffer (40 mM
Tris hydrochloride [pH 7.9], 10 mM NaCl, 6 mM MgCG2, 10
mM dithiothreitol, 2 mM spermidine), 500 puM each ATP,
GTP, and CTP (Sigma), 100 ,uCi of [a-32P]UTP (>800
Ci/mmol; New England Nuclear), and either 50 pM (MMTV
probes) or 500 p.M (tubulin probe) cold UTP. The synthesis
reactions were for 20 min at 37°C, after which the reaction
mixtures were extracted with phenol in the presence of 100
,ug of yeast RNA (Boehringer Mannheim). Unincorporated
nucleotides were removed by P-10 (Bio-Rad Laboratories)
"ispin column" (37) gel exclusion chromatography. The
probes were stored under ethanol until needed. This proto-
col generated 200 to 300 ng of RNA, of which greater than
95% was full length as judged by gel electrophoresis. MMTV
probes had a specific activity of 3 x 108 to 5 x 108 cpm/p.g.
For RNase Ti protection experiments (a modification of,
the procedure of Zinn et al. [69]), enough probe for 5 x 105
cpm ofMMTV probe and 5 x 104 cpm of P-tubulin probe per
reaction was precipitated in the same tube and then resus-
pended in hybridization buffer (80% deionized formamide,
400 mM NaCl, 40 mM PIPES [piperazine-N-N'-bis {2-ethane
sulfonic acid}] [pH 6.4], 1 mM EDTA). Total RNA from
transfected cells was prepared by dissolving cells in 6 M
guanidinium thiocyanate (7) and pelleting the RNA by cen-
trifugation through CsCl (11). RNA concentrations were
determined by A260. Ethanol-precipitated samples consisting
of 25 pug (see Fig. 2A and SG) or 15 p.g (see Fig. 7) of RNA
from transfected cells and yeast RNA to a total of 50 ,ug were
then resuspended in 20 p.1 of the probe-hybridization buffer
mix. The RNAs were denatured at 85°C for 10 min and
allowed to hybridize overnight at 55°C. A 300-,ul volume of
RNase Ti (Bethesda Research Laboratories) at a concentra-
tion of 330 U/ml in RNase digestion buffer (10 mM Tris
hydrochloride [pH 7.6], 300 mM NaCl, 1 mM EDTA) was
added, and the samples were incubated for 1 h at 30°G. The
RNase reaction was stopped by the addition of 20 p.l of 10%
sodium dodecyl sulfate and 5 p.1 of a 10-mg/ml proteinase K
(Bethesda Research Laboratories) solution followed by in-
cubation for 15 min at 37°C. After phenol extraction and
ethanol precipitation, the RNAs were suspended in 5 p.l of
gel loading buffer (80% deionized formamide, 10 mM NaOH,
1 mM EDTA, 0.1% bromophenol blue, 0.1% xylene cyanol)
and denatured for 10 min at 85°C, and the protected frag-
ments were separated on a 7% polyacrylamide gel containing
7 M urea. For quantitation of RNA, the gels were dried and
exposed for various times to Kodak XAR-5 film without an
intensifying screen. The resulting autoradiograms were
scanned by using a Zeineh soft laser scanning densitometer
(Biomed Instruments, Inc., Fullerton, Calif.), and the inten-
sity of the protected fragment corresponding to transcripts
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FIG. 2. Hormone inducibility of MMTV-CAT gene expression
directed by pLC1. Ltk- cells were transfected with pLC1, and
dexamethasone (10-' M) was added 40 h later. At various times
subsequent to hormone addition, either total cellular RNA or crude
cell extracts were prepared. (A) Analysis of MMTV-CAT tran-
scripts by nuclease protection. Uniformly labeled RNA probes of
1,170 (MMTV) and 212 (P-tubulin) nucleotides (nt) were synthesized
in vitro with T7 RNA polymerase; plasmids containing the 1.5-kb
PstI fragment from the MMTV LTR or the 1.2-kb EcoRI fragment of
mouse 3-tubulin cDNA were linearized with ClaI or BamHI,
respectively, before probe synthesis (see diagram). RNA samples
were hybridized to a mixture of these probes and then treated with
RNase Ti. Protected fragments are displayed as an autoradiogram
after fractionation by polyacrylamide-urea gel electrophoresis. RNA
samples consisted of 50 pLg of yeast RNA (lane 1) or 25 ,ug of yeast
RNA mixed with 25 F.g of total cellular RNA from transfected cells
incubated in the presence of dexamethasone for 0 h (lane 2), 6 h
(lane 3), 12 h (lane 4), 18 h (lane 5) or 24 h (lane 6). The positions of
protected fragments of 274 and 194 nucleotides expected from
MMTV promoter-specific (+ 1) and mouse P-tubulin (1) RNAs,
respectively, are indicated. In-vitro-generated RNA markers are
also included (lane 7). Independent experiments with the separate
probes verified the origins of the protected fragments (data not
shown). (B) Kinetics of induction of MMTV-CAT RNA and CAT
RESULTS
Transient-expression assay for glucocorticoid-inducible
gene expression. To study glucocorticoid hormone-regulated
gene expression in vivo, we utilized a transient-expression
assay system in which the activity of the glucocorticoid-
responsive MMTV promoter could be monitored by way of
expression of the CAT gene. As there is no enzymatic
activity comparable to CAT in mammalian cells, this system
is convenient for analyzing gene expression from various
plasmid constructs in a rapid and sensitive way (15).
All of our experiments were performed with mouse Ltk-
cells (23); this cell line is easily transfected and has been
widely used to study hormone-regulated MMTV gene ex-
pression (19, 30, 41, 43, 68). In preliminary transfection
experiments with a plasmid in which the CAT gene was
under the direction of the non-hormone-responsive SV40
early promoter, CAT enzyme activity was not hormone
inducible in the presence of 10' M dexamethasone, a
synthetic glucocorticoid (data not shown). Thus, glucocorti-
coids do not induce increased gene expression from
transfected DNA in general, and furthermore, the stability of
both the CAT protein and this mRNA are insensitive to
hormone.
Before attempting to utilize CAT activity as a measure of
glucocorticoid-inducible gene expression, we first investi-
gated the kinetics of hormone induction for both CAT
enzyme activity and CAT RNA synthesized from the
MMTV promoter. Plasmid pLCl was constructed for these
initial studies (Fig. 1B). In contrast to plasmid constructions
in other studies in which transient-expression assays have
been used to analyze hormone inducibility (25, 38), no other
known eucaryotic promoter or enhancer sequences are
located on pLCl.
To investigate the hormone-mediated induction of CAT
activity, pLC1 was transfected into mouse Ltk- cells by the
DEAE-dextran-DMSO shock procedure (28). The plasmid
concentration during this and all subsequent transfections
was 1.2 nM, corresponding to 5 ,ug of pLC1 per ml; this
concentration was reported by Lopata et al. (28) to be
optimal for transfection of L cells, a result which we have
independently confirmed (data not shown). At 40 h after
transfection, dexamethasone was added to a final concentra-
tion of 10-7 M, and crude cell extracts were prepared and
assayed for CAT activity (15) and total protein (3) at various
times after hormone addition (Fig. 2B). Under these condi-
tions, CAT enzyme activity reached a maximal level within
12 h after hormone addition, and this level was maintained
between 12 and at least 36 h. CAT activity from pLC1 was
induced approximately 350-fold by the addition of
dexamethasone.
The kinetics of MMTV-CAT RNA induction were deter-
mined by using a quantitative RNase Ti protection assay. At
enzyme activity. The relative concentration of MMTV-CAT RNA
(O) was determined by densitometic scanning of the autoradiogram
shown in panel A as described in the text. CAT enzyme activities
(0) were determined in a parallel experiment and are based on
assays containing 40 ,ug of protein from crude extracts of transfected
cells. The CAT activities are reported relative to the average of that
obtained between 12 and 36 h, from which there is less than 20%o
variation for any given time point.
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40 h after transfection with pLC1, dexamethasone was
added to l0' M, and total cellular RNA was isolated at
various later times. Transcripts initiated at the expected
position in the MMTV LTR (58) protected a 274-nucleotide
fragment of the MMTV probe (indicated by + 1), whereas
,-tubulin mRNA protected a 194-nucleotide fragment of the
,-tubulin probe (indicated by ,) (Fig. 2A). The results of this
experiment show that the amount of correctly initiated RNA
from the MMTV promoter relative to the amount of 1B-
tubulin RNA (Fig. 2B) reached a maximum 6 to 12 h after
hormone treatment, after which the RNA levels decreased to
56% maximal at 18 h and 47% maximal at 24 h. This decrease
was expected because of the continued growth of the cells
throughout the time course of the assay and the lack of
replication of pLC1 (see below). In addition to quantitating
the relative concentration of MMTV-CAT RNA, this RNase
protection experiment, along with Si nuclease protection
experiments (1) with a 5'-end-labeled probe (data not
shown), confirmed that the hormone-inducible transcripts
directed by plasmid pLC1 initiate at the correct site within
the MMTV LTR. In this experiment an additional fragment
from the MMTV probe of approximately 800 nucleotides
was also protected; this fragment was observed with RNA
from untreated as well as dexamethasone-treated cells and
therefore does not represent a functional CAT mRNA.
Taken together, the kinetics of induction of CAT enzyme
activity and MMTV-CAT RNA (Fig. 2B) indicate that, under
the conditions employed, the CAT activity measured 12 h or
later after the addition of dexamethasone reflects a steady-
state level of hormone-inducible gene expression, provides a
measure of the maximal amount of MMTV-CAT RNA, and
is not a sensitive function of the time of cell harvest. Unless
otherwise noted, cells were harvested 18 h after the addition
of dexamethasone in all transfection experiments described
in the remainder of this paper.
Increased gene expression when LTRs flank a regulated
transcription unit. As a consequence of the retroviral repli-
cation strategy, the GRE sequences sufficient for hormone
inducibility of MMTV are located at both ends of the
proviral genome within the LTRs (Fig. 1A). We initially
investigated whether a plasmid construct with a similar gene
structure could give rise to a different level of gene expres-
sion than that from a plasmid which contains GRE se-
quences only 5' of the promoter. Plasmid pLCL1 (Fig. 1C)
was constructed for this purpose. This plasmid is identical to
pLC1 except that 191 bp of pBR322-derived sequences from
BamHI to SphI were replaced with a second copy of the
MMTV LTR identical to that placed 5' of the gene. In the
MMTV provirus, the GRE sequences in the 3' LTR are
upstream of the MMTV poly(A) signal and are thus encoded
in the 3' end of the viral RNAs. However, to avoid compli-
cating effects of GRE sequences on parameters other than
transcription initiation that are potentially under hormone
control (4, 32), the SV40 early poly(A) signal was retained
upstream of the 3' LTR in pLCL1.
When transfected into Ltk- cells, the hormone-inducible
CAT activity directed by pLCL1 was 1.7 times that of pLC1
(Fig. 3), while in the absence of added hormone, the CAT
activity of pLCL1 was essentially the same as that of pLC1
(data not shown). Therefore, this increase in CAT expres-
sion is due not to a general increase in the transcriptional
activity of one plasmid construction over the other, but
rather is specifically mediated by glucocorticoid hormones.
A complicating factor in interpreting these results is that,
while having additional GRE sequences downstream of the
CAT gene, pLCL1 also contains an additional MMTV pro-
1 2
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FIG. 3. An additional LTR increases CAT activity. Cells were
transfected with equimolar amounts of plasmid, and after 40 h,
dexamethasone was added to lo-7 M. After 18 h, cell extracts were
prepared, and equal amounts of protein were assayed for CAT
activity. Shown is an autoradiogram of the thin-layer chromatogra-
phy plate from a representative assay for cells transfected with
pLC1 (lane 1) and pLCL1 (lane 2). The two faster-migrating spots
correspond to the 3-acetyl and 1-acetyl derivatives of chloramphen-
icol, while the slower-migrating spot is the unmodified substrate.
CAT activity is expressed relative to the specific activity of an
extract from cells transfected with pLC1 (arbitrarily set to 100). The
relative activities reported are the average of four transfection
experiments.
moter in the 3' LTR, and this experiment does not differen-
tiate between the possible effects of this second promoter on
CAT activity from those mediated only by the additional
GRE sequences.
3' LTR can be replaced by a functional GRE. We sought to
determine whether the sequences responsible for the 1.7-fold
enhancement of dexamethasone-inducible CAT activty from
pLCL1 over that from pLC1 could be localized to the GRE
region of the MMTV LTR. To this end we constructed
plasmid pLC1.3A, in which the 344-bp Sau3A fragment of
the MMTV LTR (Fig. 1) was inserted into pLC1 at the
BamHI site downstream of the CAT transcription unit (Fig.
4A). This Sau3A fragment has been shown to contain a
functional GRE (6), even though it is missing approximately
30 bp of DNA that has been implicated in some studies as
involved in both hormone induction in vivo (43) and receptor
binding in vitro (48, 49). In pLC1.3A the GRE sequences are
in the same orientation with respect to the transcription unit
as those in the 3' LTR of pLCL1, and these additional
sequences were again inserted outside the transcription unit.
Hormone-inducible CAT activity directed by pLC1.3A in
transfected cells was 1.5-fold higher than that directed by
pLC1 (Fig. 4B), confirming that GRE sequences were, in
large part, sufficient to substitute for the 3' LTR in regulated
transcription units flanked by LTRs.
To investigate the position and orientation specificity of
this additional GRE on hormone-inducible transcription, we
constructed plasmids pLC1.5A, pLC1.5B, and pLC1.3B
(Fig. 4A). These plasmids, together with pLC1.3A, contain
the 344-bp Sau3A fragment of the MMTV LTR inserted into
the BamHI sites of pLC1 at either the 5' (pLC1.5) or 3'
(pLC1.3) end of the transcription unit in each of the two
possible orientations (A or B). Transfection of pLC1.5A
resulted in a hormone-inducible CAT activity 1.8-fold
MOL. CELL. BIOL.
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FIG. 4. Position and orientation dependence of additional GREs. (A) Structure of pLCl.5/3. The 344-bp Sau3A fragment from the MMTV
LTR (Fig. 1) was inserted into the BamHI sites ofpLC1 at either the 5' (pLC1.5 plasmids) or the 3' (pLC1.3 plasmids) end of the MMTV-CAT
transcription unit. Insertions in both orientations (A and B) were obtained. (B) Representative autoradiogram of CAT assays performed and
reported as in the legend to Fig. 3. Extracts were prepared from cells transfected with equimolar amounts of pLC1 (lanes 1 and 4), pLC1.5A
(lane 2), pLC1.3A (lane 3), pLC1.5B (lane 5), or pLC1.3B (lane 6). The relative CAT activities reported are the average of at least three
transfection experiments.
greater than that of pLC1 and thus roughly comparable to
the CAT activity of both pLCL1 and pLC1.3A; this result
suggests that the effect of an additional GRE is relatively
independent of position with respect to the promoter to
which it is linked. Similar results have been observed by
others in comparing gene constructs containing a single GRE
with those containing no GRE sequences (43). In contrast to
the results with pLC1.3A and pLC1.5A, transfection of
pLC1.5B failed to show any increase in hormone-inducible
CAT activity relative to pLCl, and transfection of pLC1.3B
also led to less hormone-inducible CAT activity than the
comparable construction with the Sau3A fragment in the
normal orientation (Fig. 4B). These results were consistently
obtained in multiple transfections with independent plasmid
DNA preparations.
Taken together, the CAT activities derived from the
pLC1.5 and pLC1.3 plasmids indicate that the increases in
transcription due to the presence of additional GRE se-
quences is independent of the position but, in these sequence
contexts, not the orientation of the added Sau3A fragment
with respect to the gene (see below).
Effects of multiple GREs are additive. To address the
possibility that further increases in the number of GREs
might lead to additional activity from the MMTV promoter
and, if so, to quantitate the nature of this increase, we
constructed plasmid pLC1.5AA, in which two 344-bp Sau3A
fragments were inserted in tandem into the BamHI site
located 5' of the MMTV LTR in pLC1 (Fig. 4A). In
pLC1.5AA both Sau3A fragments were inserted in the same
orientation as that in the intact LTR. The hormone-inducible
CAT activity directed by pLC1.5AA was 2.9 times that
directed by pLC1 (Fig. 5A), which confirmed our earlier
A
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FIG. 5. Effect of multiple glucocorticoid receptor binding sites on the MMTV promoter. Plasmids containig either tandemly duplicated
Sau3A fragments inserted 5' of the MMTV-CAT transcription unit (pLC1.5AA) or a 1.3-kb BamHI fragment containing internal binding sites
2 and 3 (Fig. 1) inserted 3' of the MMTV-CAT transcription unit (p23LC1) were tested for their ability to affect transcription from the MMTV
promoter. In both plasmids the insertions were into the BamHI sites of pLCi in the A (correct) orientation with respect to the promoter (Fig.
4A). (A) Effect of multiple GREs. A representative autoradiogram of CAT enzyme assays of extracts prepared from cells transfected with
equimolar amounts of pLC1 (lanes 1 and 2), pLC1.SA (lanes 3 and 4), and pLC1.5AA (lanes 5 and 6) is shown. Assays were performed and
reported as in the legend to Fig. 3 except that some cells were maintained in the absence of dexamethasone (DEX) (lanes 1, 3, and 5), while
others were treated with hormone as described (lanes 2, 4, and 6). The relative CAT activities are the average of at least five determinations.
(B) Effect of internal receptor binding sites 2 and 3. A representative autoradiogram of CAT enzyme assays performed and reported as in the
legend to Fig. 3 is shown. Extracts were prepared from cells transfected with pLC1 (lane 1) or p23LC1 (lane 2) and treated with
dexamethasone. The relative CAT activities are the average of three determinations. (C) RNase Ti protection analysis of MMTV-CAT
transcripts from plasmids containing multiple GREs. Uniformly labeled RNA probes of 414 (MMTV) and 212 (P-tubulin) nucleotides (nt) were
synthesized in vitro with T7 RNA polymerase And were utilized in an RNase Ti protection experiment as described in the legend to Fig. 2;
in this experiment the MMTV probe was synthesized from a plasmid linearized at the Sstl site in the LTR (see diagram). RNA samples
consisted of 25 pug of total RNA from cells transfected with pLC1 (lanes 1 and 2), pLC1.5A (lane 3), or pLC1.5AA (lane 4). At 40 h after
transfection, cells were incubated for an additional 18 h in the absence (lane 1) or presence (lanes 2, 3, and 4) of 1O-7 M dexamethasone. The
positions of protected fragments of 274 and 194 nucleotides expected from MMTV promoter-specific (+ 1) and P-tubulin (3) RNAs,
respectively, are indicated. In-vitro-generated RNA markers (lane 5) are also shown.
-4
0 CO
a a
100 95
MMTV LTR
cr
MOUSE
-TUBULIN
08I)
MOL. CELL. BIOL.
 o
n
 Septem
ber 12, 2018 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
MULTIPLE HORMONE-INDUCIBLE ENHANCERS 4533
z
300-.
CO)
CO)
w
0.
w
I-200-
100-
X-J
w
1 2 3
NUMBER OF GREs
FIG. 6. Additive effects of multiple GREs. The relative concen-
tration of MMTV-CAT RNA, as determined by densitometric
scanning of the autoradiogram in Fig. 5C (open bars), and the
relative CAT enzyme activity (filled bars) in extracts of transfected
cells is shown as a function of the number of GRE-containing Sau3A
fragments present at the 5' end of the MMTV-CAT transcription
unit. Plasmids pLC1, pLC1.5A, and pLC1.5AA correspond to one,
two, and three GREs, respectively.
observation that the MMTV promoter is not fully induced by
the single GRE normally present in the LTR (pLC1) and
further indicated that the promoter is also not maximally
induced when associated with two GREs (pLC1.SA).
To verify that the increased CAT activity seen in cells
transfected with the various plasmids containing multiple
GREs was due to increased levels of correctly initiated
MMTV-CAT RNA, we performed an RNase Ti protection
experiment (Fig. 5C). As expected, a fragment of 274 nucle-
otides, corresponding to transcripts initiated at the MMTV
promoter, was protected in RNA from hormone-treated cells
but not in RNA from untreated cells. Densitometric scanning
of the autoradiogram in Fig. 5C indicated that the relative
levels of MMTV promoter-specific RNA from cells
transfected with constructs containing multiple GREs corre-
lated very well with the relative CAT activities derived from
these plasmids; furthermore, the increases in transcription
from the MMTV promoter were additive with respect to the
number of GREs present on the plasmid (Fig. 6). A second
protected fragment from the MMTV probe of 390 nucleo-
tides was also detected (Fig. 5C). The origin of this fragment
may be the same as that of the protected fragment of about
800 nucleotides observed in Fig. 2A, as again it is present in
RNA from cells not treated with dexamethasone. These
results show that the relative levels of CAT activity in cells
transfected with plasmids containing multiple GREs can be
completely accounted for by the relative abundance of
transcripts initiated at the MMTV promoter.
Having shown that multiple GREs have the potential to
increase transcription from the MMTV promoter, we inves-
tigated whether sequences internal to the MMTV genome
that have been defined as lower-affinity glucocorticoid re-
ceptor binding sites in vitro were able to act in a similar
fashion. A 1.3-kb BamHI fragment (Fig. 1A) of the MMTV
genome containing internal binding sites 2 and 3 (40) was
inserted into the 3' BamHI site in pLC1 to form plasmid
p23LC1; the orientation of these additional sequences is the
same with respect to the MMTV LTR as those in the intact
provirus. Upon transfection into Ltk- cells, p23LC1 di-
rected levels of CAT activity comparable to pLC1 both in
the presence (Fig. 5B) and in the absence (data not shown) of
dexamethasone.
Multiple GRE effects are not due to differential transfection
efficiencies. Neither the CAT assays nor the RNase Ti
protection experiments described above address the possi-
bility that the differences in activity derived from plasmids
containing multiple GREs were due to variability in trans-
fection efficiency. We therefore performed a second RNase
Ti protection experiment in which we incorporated a co-
transfected reference plasmid whose transcriptional activity
could be used to monitor this parameter (Fig. 7). Plasmid
pLC2, which contains the PstI-PvuII fragment of the MMTV
LTR upstream of the CAT coding sequences, was con-
structed for this purpose. The level of correctly initiated
transcripts (indicated by + 1) from pLC1.SAA (Fig. 7, lane 4)
relative to those from pLC2 (indicated by +1*) was clearly
greater than that of pLC1 (Fig. 7, lane 3).
In this experiment a protected fragment from a mouse
P-tubulin probe (indicated by 3) again served as an internal
standard. Densitometric scanning of the autoradiogram in
Fig. 7 indicated that, while expression from pLC2 was
identical in each transfection, the level of steady-state RNA
directed by pLC1.SAA was 2.7 times that of pLCl. These
results confirm that differences in transfection efficiency
were not responsible for the differences in activity directed
by these plasmids. Furthermore, competition between the
promoters in pLC1 and pLC2 was not evident in this
experiment (compare Fig. 7, lanes 2 and 3), suggesting that
the availability of trans-acting transcription factors was not
limiting under these conditions.
Two protected fragments, in addition to those expected,
were also evident in this experiment. The fragment appear-
ing just above the 1-tubulin protected band is derived from
pLC2 and most likely corresponds to the fragments of 800
nucleotides in Fig. 2A and 390 nucleotides in Fig. 5C. The
other fragment, appearing below the 1-tubulin control, was
also detected in Si nuclease protection experiments by using
a 5'-end-labeled probe (data not shown) and is derived from
a hormone-responsive transcriptional start site downstream
of the normal site within the MMTV LTR.
DISCUSSION
Characterization of transient-expression assay. The expres-
sion of CAT has been used previously in transient-
expression assay systems to measure both promoter (14) and
enhancer (24, 46, 51) activities. Although levels of CAT
enzyme activity and RNA have been correlated (14, 54, 63),
a characterization of this assay with a hormone-inducible
promoter has not been reported. We have analyzed the
kinetics of induction of both RNA and enzyme activity and
have compared the relative amounts of RNA and CAT
activity in cells transfected with plasmids that direct dif-
ferent levels of gene expression.
Kinetics of induction (Fig. 2) revealed that relative CAT
enzyme activity reaches a constant level 12 h after hormone
addition, whereas the relative concentration ofMMTV-CAT
RNA reaches a maximal level between 6 and 12 h after
hormone addition and then declines. These kinetics are
predicted if the transfected DNA is not replicated. We have
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not obtained any evidence for replication of our plasmids in
Ltk- cells; sites of adenine methylation introduced by the
dam' E. coli strain in which the plasmids were amplified are
not lost upon transfection (data not shown). Thus, even if the
transfected DNA is not degraded and the rate of RNA
synthesis from each transfected DNA template is not al-
tered, the relative concentrations of RNA and protein gene
products synthesized from the transfected plasmid com-
pared with those synthesized from endogenous cellular
genes would eventually be expected to decrease with time.
These time course data show that CAT activity measured 18
h after the addition of hormone reflects the maximum CAT
activity transiently expressed by the transfected cells and
that this activity is not a sensitive function of time.
Our results indicate that relative CAT enzyme activity is a
linear function of the relative concentration of MMTV-CAT
RNA at a specific time in the transient-expression assay
(Fig. 6). In addition to the results in Fig. 6, we have also
observed a linear correlation between CAT activity and
RNA levels from four other MMTV-CAT constructs, each
with a different relative activity (data not shown).
We have investigated the copy number of plasmid DNA in
the nuclei of transfected cells. Quantitative Southern blots
(55) in which the hybridization of plasmid sequences was
compared with that of endogenous MMTV DNA in Ltk-
cells indicated that the average number of plasmid molecules
per nucleus is approximately 30. This value is reproducible
between independent transfections and is unchanged in
experiments with plasmids that direct different levels of CAT
gene expression (data not shown). The differential levels of
hormone-inducible CAT activity reported here are thus
unlikely to be the result of copy number effects of the
different plasmid constructions.
It has been reported that transient-expression assay of
CAT enzyme activity is not highly reproducible (17), most
likely as a result of differences in transfection efficiency for
different plates. We have not found this to be the case under
the conditions we use for transient-expression assays. With
a single exception, the CAT activity measured under our
experimental conditions and over a number of trials is
always within 20%, and in many cases within 10%, of the
reported mean values. This high level of reproducibility is
most likely due to a combination of pooling the cells before
plating for transfection, performing transfections at a cell
density low enough to ensure subconfluent monolayers at
harvest (i.e., avoiding growth arrest), and normalizing CAT
activity to total protein (i.e., correcting for variable cell
growth and recovery of protein during extract preparation).
Contrary to reports elsewhere (18, 25, 26, 38), our results
clearly demonstrate that the MMTV promoter-enhancer
does not require additional heterologous enhancer elements
for use in a transient-expression assay system. The differ-
ences between our results and those of others appear to be
related to the absence in our plasmids of specific, cis-acting,
pBR322 sequences that decrease transient expression from
the MMTV and other promoters (D. Peterson, K. Beifuss,
and K. Morley, submitted for publication).
Role of multiple GRE sequences in MMTV. MMTV DNA
contains functional GRE sequences in the LTRs at each end
of the proviral genome, and our initial studies on multiple
enhancer effects sought to determine the significance of this
sequence organization on transcription initiation from the
upstream MMTV promoter. CAT gene expression in a
transient-expression assay with the plasmids pLCL1 and
pLCl (Fig. 3) indicated that the effect of a second LTR
located 3' of the regulated transcription unit is to increase
1 2 3 4
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FIG. 7. Increased MMTV-CAT activity is not due to differential
transfection efficiencies. Cells were transfected with pLC1 (1.2 nM),
pLC1 (1.2 nM) and pLC2 (0.60 nM), or pLC1.5AA (1.2 nM) and
pLC2 (0.60 nM). The total DNA concentration in each transfection
was brought to 11.0 pug/ml with plasmid pMT1, which is identical to
pLCl except that the MMTV LTR and CAT coding sequences have
been removed. Total RNA was prepared 12 h after the addition of
dexamethasone (10-7 M). The probes used are identical to those
used in Fig. 5. RNA samples consisted of 50 ,ug of yeast RNA (lane
1) or 35 ,ug of yeast RNA and 15 ,ug of total RNA from cells
transfected with pLC1 (lane 2), pLC1 and pLC2 (lane 3), and
pLC1.5AA and pLC2 (lane 4) and were treated with RNase Ti as
described in the text. The position of the 274-nucleotide (nt)
fragment corresponding to correct initation from pLC1 and
pLC1.5AA is indicated (+1) as is the position of the 135-nucleotide
fragment derived from correctly initiated transcripts from the refer-
ence plasmid, pLC2 (+ 1*), and the 194-nucleotide fragment derived
from mouse P-tubulin mRNA (p).
transcription from the upstream MMTV promoter. It thus
appears that the absolute levels of transcriptional enhance-
ment of the intact MMTV provirus in the presence of
glucocorticoid hormones may be due in some part to the
repeated sequences flanking the provirus. This experiment
suggested that the extent of hormone-inducible transcription
initiation could be quantitatively modulated by the number
of GRE sequences linked to a regulated transcription unit.
As we had hypothesized, GRE sequences alone are sufficient
for the enhancement of transcription observed with a com-
plete LTR in pLCL1 provided they are in the correct
orientation with respect to the promoter (Fig. 4). Further-
more, this increased activation of the MMTV promoter is
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not the result of differential transfection efficiencies of the
various plasmids (Fig. 7).
The results presented here clearly indicate that the MMTV
promoter is not at maximal activity when under the influence
of either one or two GRE sequences (Fig. 5 to 7). These
results are consistent with the suggestion (40, 41) that the
glucocorticoid receptor binding sites internal to the MMTV
genome may serve as additional GREs that act to enhance
transcription from the MMTV promoter. However, in a
direct test of this proposal, a 1.3-kb BamHI restriction
fragment containing two of these internal binding sites (40)
was shown to have no detectable effect on the transcription
from a proviral promoter contained within an intact LTR
(Fig. SB). This fragment was located 3' of the promoter in a
sequence organization that in some respects mimics its
position in a complete MMTV provirus. We have also been
unable to demonstrate GRE activity on this fragment when
linked in four different sequence contexts to a truncated
MMTV LTR (position -110 to +274) which shows only a
small hormone response in comparison with that of the intact
LTR (unpublished data). The glucocorticoid receptor bind-
ing sites located on this 1.3-kb BamHI fragment have been
reported to be of lower affinity than those in the LTR (40),
and such differences in affinity may correlate with the ability
of the sequences to function as GREs (53). It is possible,
however, that the combined action of a larger number of
receptor binding sites that function as very weak GREs may
have a significant effect on the MMTV promoter which was
not detected in our assays of two isolated sites or that the
internal receptor binding sites are functioning by a biochem-
ical mechanism distinct from that of the GRE that is directly
related to their normal position within the transcribed por-
tion of the provirus.
MMTV GRE as a transcriptional enhancer. In light of
studies by others (6, 43), the orientation dependence we
observed in multiple GRE constructions was unexpected
and, since based on a small of number plasmid construc-
tions, must be interpreted with caution. These conflicting
results, however, may have arisen because our system
significantly differs from others in which orientation-
independent function was reported for the MMTV GRE. In
one of these systems (6), the plasmid sequences for testing
the reverse orientation of the GRE had two Sau3A fragments
linked to the herpes simplex virus thymidine kinase pro-
moter and were stably integrated into the genome; the
sequence organization of the transformed DNA was not
characterized. If, as is often the case, these sequences were
inserted in tandem linear arrays, each internal transcription
unit was then flanked by a total of four GREs, two of which
were 3' of the promoter in a position and orientation in which
we also detect transcriptional enhancement. In the other
system (43), the sequences that were used contained a more
complete GRE receptor-binding domain than that contained
on the Sau3A fragment used in the present study (49). It is
possible that the sequences necessary for maximal hormone
activation from the reversed orientation of the GRE resides
on two separable sequence elements. Also, in contrast to our
transient-expression assay system, the plasmid construc-
tions used in the latter experiments contained not only those
constituting the previously defined hormone response ele-
ment, but also sequences containing internal binding site 4
(Fig. 1), as well as an SV40 enhancer region, the presence of
which may have independently affected glucocorticoid-
responsive transcription (41). Finally, we have localized a
negative transcriptional control element to the same 344-bp
Sau3A fragment that contains the GRE sequences used in
this study (K. Morley, M. Toohey, and D. Peterson, submit-
ted for publication); the reverse orientation of this fragment
appears to magnify the negative effect on the MMTV pro-
moter, especially at an insertion site 5' of the promoter.
Thus, the absolute level of transcriptional enhancement
observed here may be affected by the presence of both
positive and negative elements on the inserted Sau3A frag-
ment and may be determined in part by the relative positions
of the two elements with respect to the promoter.
It has been suggested that the functional differences be-
tween enhancer elements and other RNA polymerase II
control elements may be only one of degree (52, 64). In
support of this view, both the SV40 21-bp repeats (36) and
the herpes simplex virus thymidine kinase upstream ele-
ments (33) show some enhancerlike activity in that they can
stimulate transcription when placed in the opposite orienta-
tion. Furthermore, the enhancers of SV40 (8) and polyoma
(17) which are generally considered to be bidirectional
regulatory elements, show a marked directional preference
in at least some sequence contexts. It is not yet clear where
in the functional spectrum of these regulatory sequences the
MMTV GRE resides, although our data suggest that the
GRE sequences contained on the 344-bp Sau3A fragment
show relatively little distance-position dependence but do, in
at least some sequence contexts, show an orientation depen-
dence.
Multiple enhancers and differential transcription. Many of
the RNA polymerase II promoter sequences defined to date
consist of either large direct repeats or smaller regions
containing well-conserved, multiply repeated regions (for a
review, see reference 12). In the best characterized of these
elements (6, 20, 35, 39, 51, 52), these repeated regions have
been shown to require trans-acting factors capable of stim-
ulating transcription from a linked promoter. The cis-acting
DNA sequences for several systems which are under the
regulatory control of more than one pathway have been
defined. These regions generally adhere to the above gener-
alization of repeating elements. In these cases, however, the
repeated elements are clustered into groups, either physi-
cally separate from one another (21) or overlapping (44, 62),
each of which carries the sequences responsible for the
transcriptional response due to a particular biochemical
signal. One view of this type of regulatory region is that
different enhancers can act independently to stimulate tran-
scription in response to different biochemical states within
the cell (66). An extension of this view is that differential
regulation of separate genes under the same type of bio-
chemical control can be conferred by different numbers of a
specific type of enhancer element associated with each gene
(13, 33, 52). We tested this latter possibility in our experi-
mental system.
The insertion of GRE sequences upstream of the intact
MMTV LTR resulted in additive increases in the glucocor-
ticoid-inducible activity of the MMTV promoter (Fig. 6).
Whether this effect is mediated by multiple hormone recep-
tor binding events or by the increased probability of a single
binding event on plasmids with multiple GREs is unclear.
Either mechanism is possible, not only for multiple tran-
scription templates introduced by transfection, but also for
single-copy genes, and the two mechanisms are not mutually
exclusive. The lack of detectable competition between plas-
mids containing identical hormone-responsive promoters
(Fig. 7) suggests that we have not titrated the trans-acting
transcription factors required for a multiple binding event
mechanism.
Experiments from other laboratories support the idea that
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our results may be indicative of a general regulatory strat-
egy. After the completion of our work, a series of plasmid
constructs with increasing numbers of sequence elements
conferring a metal response to the mouse metallothionein II
gene was reported to result in increasing amounts of metal-
inducible RNA from the herpes simplex virus thymidine
kinase promoter (56). The repeat units used in these exper-
iments were much smaller than those in the present study,
suggesting that the additive response described here may
work at the levels of both single repeat units or groups of
these elements. It also should be noted that the human
growth hormone gene has recently been shown to have a
functional GRE located within its first intron (53) in addition
to the previously defined GRE located 5' of the transcription
initiation site (45). Although it has not been investigated, it is
tempting to speculate that glucocorticoid regulation of this
gene is under the control of multiple hormone-responsive
enhancer elements.
In conclusion, our results give direct support for the
proposal that differential levels of transcription may be
controlled in part by the number of functional enhancer
elements associated with particular transcription units. In
the specific case of glucocorticoid-responsive transcription
described here, further increases in the number of GREs
associated with the MMTV promoter would eventually be
expected to saturate the level of transcription as some
parameter, other than that which is supplied by the GRE,
becomes rate limiting. Determination of the number ofGREs
necessary to reach, and the transcriptional activity at, this
saturation point will help define the range of transcriptional
modulation afforded by the multiple enhancer mechanism.
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